Home Markets Q32 Bio: Oppenheimer slashes price target on mixed trial results

Q32 Bio: Oppenheimer slashes price target on mixed trial results

Dec 11, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/q32-bio-oppenheimer-slashes-price-target–on-mixed-trial-results-3765273

You May Also Like

US stock futures inch lower with China trade talks, inflation data in focus

European Chemicals sector outlook for 2025 and 2026: UBS

UnitedHealth: Bernstein lists 3 top priorities for the new CEO

Israel stocks higher at close of trade; TA 35 up 0.03%

What’s next for Fannie and Freddie under Trump administration?

Is the stage finally set for transcontinental rail mergers?